Dose-Escalation Study of the Safety and Immunogenicity of a Novel Rabies Vaccine ChAd155-RG vs. the Comparator RABAVERT Vaccine in Healthy Adult Subjects

Conditions:   Rabies;   Rabies Immunisation Interventions:   Biological: ChAd155-RG;   Other: Placebo;   Biological: Rabies Vaccine Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials